[1]
“Adjuvant Intravesical Chemotherapy in the Management of Superficial Transitional Cell Carcinoma of Urinary Bladder Following Transurethral Resection of Bladder Tumor- Result of Single Dose and Multiple doses of Mitomycin C”, Bang J Urology, vol. 23, no. 1, pp. 62–66, Nov. 2020, doi: 10.3329/bju.v23i1.50292.